Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis. - Wikidata - awgldk - TriplyDB

Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.

Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.

http://www.wikidata.org/entity/Q52891891

about

IL-6 and IGF-1 Signaling Within and Between Muscle and Bone: How Important is the mTOR Pathway for Bone Metabolism?PPARD is an Inhibitor of Cartilage Growth in External Ears The role of small molecules in musculoskeletal regeneration.TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation Osteoclasts-Key Players in Skeletal Health and Disease.Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.Implications of the Interaction Between miRNAs and Autophagy in Osteoporosis.Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management.Glucose-dependent downregulation of glucagon gene expression mediated by selective interactions between ALX3 and PAX6 in mouse alpha cells.Mammalian target of rapamycin as a therapeutic target in osteoporosis.Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation.Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.Autophagy: a new player in skeletal maintenance?

P2860

Q27024703-7A542478-4DFB-46B8-AD9F-FD32B8A7015E Q33717803-1BE56F96-1E0E-44E7-9246-96FB8464D752 Q34346326-A0177FDC-4ED9-4D22-8D20-EC1D12A95FB5 Q35145474-238A6F57-6825-46B5-B75A-7B6402937526 Q37036135-1B4E45C8-ED26-4A6E-93C3-24F909FF522A Q38092683-2C478322-6C92-47E8-915C-0EAB3FF9608C Q38753100-C574DB24-003B-4063-880E-7DC25FF87198 Q38805260-3C39E425-6DBF-4AC3-A5FC-F560B7C234F5 Q38806012-5609C6D3-01E3-43D9-88F7-5434B05C9199 Q48187280-40055B6D-DB19-4E26-ACD9-E0F6C50CB09C Q51063770-5CABF650-AAE9-4862-B0B3-65A5CE0F3E96 Q52915154-93998E88-BA8F-4F80-AB0B-D9157801A88C Q53162347-389D0120-88FD-49AB-B650-38F85E6427DB

P2860

Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.

http://www.wikidata.org/entity/Q52891891

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Rapamycin inhibits osteoclast ...... hrough the C/EBPβ - MafB axis.

@en

Rapamycin inhibits osteoclast ...... hrough the C/EBPβ - MafB axis.

@nl

type

label

Rapamycin inhibits osteoclast ...... hrough the C/EBPβ - MafB axis.

@en

Rapamycin inhibits osteoclast ...... hrough the C/EBPβ - MafB axis.

@nl

prefLabel

Rapamycin inhibits osteoclast ...... hrough the C/EBPβ - MafB axis.

@en

Rapamycin inhibits osteoclast ...... hrough the C/EBPβ - MafB axis.

@nl

P1433

Q52891891-74519C51-E958-45AD-B78F-3F7FD993064F

P1476

Q52891891-74E4BD53-C049-45F4-9354-89FB69B4EDA9

P2093

Q52891891-0BAFC30D-DD07-4D2F-ADC0-9CB2C2310F0A

Q52891891-DDBC5D7C-848D-4265-8D27-86B3FFB5C135

P2860

Q52891891-1933D9A4-26BF-4290-83E0-507C4693D0CB

Q52891891-1D1387AB-AEBB-4634-95CB-D8692F9EC6FA

Q52891891-252C627A-A718-4AAB-BA70-1259541E5E24

Q52891891-2B712338-2B80-49B0-8E45-A83A1D1D41F8

Q52891891-34FA1917-FD93-4B8F-8E98-1928FF695AA5

Q52891891-4E62058B-D5AC-4C13-8AC1-9FFB7298588F

Q52891891-626CBA9A-B1F6-4FCC-B566-14F4027AEB30

Q52891891-73789B8C-0904-40B6-9088-A62E64587090

Q52891891-73CE7826-0960-436C-B4E3-C45721557D23

Q52891891-81B65348-5404-4AD9-B6B2-444DE792EDA2

P2888

Q52891891-98F0865D-5522-4AAD-967F-D4FFD492F908

P304

Q52891891-8D4E765E-9359-4045-9E6A-BB122DDD9FA5

P31

Q52891891-06D707DE-A5B7-4780-8826-1CD6117DCF17

P356

Q52891891-B42AB977-9D4E-4251-B07A-27FB19905DCB

P433

Q52891891-6A67C15F-F9D8-4E25-9251-EF9F92ED8B86

P478

Q52891891-F729F62B-44A5-4991-9C43-6E04A2692DE9

P50

Q52891891-4867D729-BBC1-44C5-A84B-3181B1077DE6

P577

Q52891891-AF7CFE6E-DE46-4CC7-8888-EA4BD8FB44A2

P698

Q52891891-360F6163-99D4-4E62-9E93-8B886E75CEF8

P356

S00109-011-0823-6

P1433

Journal of Molecular Medicine

P1476

Rapamycin inhibits osteoclast ...... hrough the C/EBPβ - MafB axis.

@en

P2093

Jeske J Smink

http://www.w3.org/2001/XMLSchema#string

Per-Ulf Tunn

http://www.w3.org/2001/XMLSchema#string

P2860

Giant cell tumour of bone: morphological, biological and histogenetical aspects

Upstream open reading frames: molecular switches in (patho)physiology

Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation

Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.

Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer.

C/EBPbetaDeltauORF mice--a genetic model for uORF-mediated translational control in mammals.

Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB

Future anti-catabolic therapeutic targets in bone disease.

Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?

P2888

s00109-011-0823-6

P304

25-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00109-011-0823-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22071989

http://www.w3.org/2001/XMLSchema#string